| 1 |
The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis
Karen E Hughes, Mark A Bellis, Katherine A. Hardcastle et al. · The Lancet Public Health
ReviewOpen access |
31 Jul 2017 |
5,313 |
| 2 |
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al. · The Lancet
Open access765 authors |
8 Dec 2020 |
5,030 |
| 3 |
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al. · Clinical Infectious Diseases
Open access |
8 Oct 2019 |
2,973 |
| 4 |
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Oliver A. Cornely et al. · The Lancet Infectious Diseases
Open access |
4 Nov 2019 |
1,841 |
| 5 |
Real-time, portable genome sequencing for Ebola surveillance
Joshua C Quick et al. · Nature
Open access102 authors |
Feb 2016 |
1,600 |
| 6 |
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Jamie Lopez Bernal, Nick J Andrews, Charlotte Gower et al. · BMJ
Open access |
13 May 2021 |
1,398 |
| 7 |
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey et al. · The Lancet
Open access766 authors |
21 Feb 2021 |
1,213 |
| 8 |
Tackling the emerging threat of antifungal resistance to human health
Matthew C. Fisher, Ana Alastruey‐Izquierdo, Judith G. Berman et al. · Nature Reviews Microbiology
ReviewOpen access |
29 Mar 2022 |
1,185 |
| 9 |
SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp et al. · Nature
Open access1,134 authors |
5 Feb 2021 |
1,091 |
| 10 |
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Erik Volz et al. · Cell
Open access581 authors |
18 Nov 2020 |
1,086 |
| 11 |
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
Melina Arnold et al. · The Lancet Oncology
Open access |
11 Sep 2019 |
1,083 |
| 12 |
Life course health consequences and associated annual costs of adverse childhood experiences across Europe and North America: a systematic review and meta-analysis
Mark A Bellis, Karen E Hughes, Kat Ford et al. · The Lancet Public Health
ReviewOpen access |
3 Sep 2019 |
1,042 |
| 13 |
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium
William Checkley et al. · The Lancet Infectious Diseases
Open access |
30 Sep 2014 |
1,039 |
| 14 |
Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood
Hywel C Williams et al. · Journal of Allergy and Clinical Immunology
Open access |
1999 |
999 |
| 15 |
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Kevin W. Ng et al. · Science
Open access |
6 Nov 2020 |
994 |
| 16 |
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Philipp A. Koehler et al. · The Lancet Infectious Diseases
Open access |
16 Dec 2020 |
977 |
| 17 |
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett et al. · Nature Microbiology
Open access692 authors |
7 Jul 2022 |
739 |
| 18 |
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al. · Nature
Open access1,136 authors |
11 Mar 2021 |
717 |
| 19 |
The SAIL databank: linking multiple health and social care datasets
Ronan Anthony Lyons, Kerina Helen Jones, Gareth John et al. · BMC Medical Informatics and Decision Making
Open access |
16 Jan 2009 |
675 |
| 20 |
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R. W. Emary et al. · The Lancet
Open access |
30 Mar 2021 |
652 |
| 21 |
Cryptosporidium Pathogenicity and Virulence
Maha Bouzid, Paul Raymond Hunter, Rachel M. Chalmers et al. · Clinical Microbiology Reviews
Open access |
2013 |
566 |
| 22 |
The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015
Katrina Brown, Harriet Rumgay, Casey Dunlop et al. · British Journal of Cancer
Open access |
23 Mar 2018 |
565 |
| 23 |
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
Angela B. Brueggemann et al. · The Lancet Digital Health
Open access |
24 May 2021 |
555 |
| 24 |
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK
Louis du Plessis et al. · Science
Open access |
8 Jan 2021 |
524 |
| 25 |
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Mohsen Naghavi et al. · The Lancet
Open access2,463 authors |
Oct 2025 |
500 |
| 26 |
Preventing a covid-19 pandemic
John P. Watkins · BMJ
Open access |
28 Feb 2020 |
492 |
| 27 |
Return on investment of public health interventions: a systematic review
Rebecca Masters, Elspeth Anwar, Brendan Collins et al. · Journal of Epidemiology & Community Health
ReviewOpen access |
29 Mar 2017 |
487 |
| 28 |
Extreme water-related weather events and waterborne disease
Kimberley Cann, Daniel Rhys Thomas, Roland L. Salmon et al. · Epidemiology and Infection
Open access |
9 Aug 2012 |
481 |
| 29 |
A National Strategy to Diagnose Coronavirus Disease 2019–Associated Invasive Fungal Disease in the Intensive Care Unit
Philip Lewis White et al. · Clinical Infectious Diseases
Open access |
28 Aug 2020 |
455 |
| 30 |
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Martin Hoenigl, Danila Seidel, Agostinho Carvalho et al. · The Lancet Microbe
Open access |
25 Jan 2022 |
450 |
| 31 |
Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Martin C. J. Maiden, Ana Belén Ibarz-Pavón, Rachel Urwin et al. · The Journal of Infectious Diseases
Open access |
13 Feb 2008 |
444 |
| 32 |
SARS-CoV-2 within-host diversity and transmission
Katrina Lythgoe et al. · Science
Open access |
9 Mar 2021 |
442 |
| 33 |
Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19
Davey L. Jones, Marcos Quintela‐Baluja, David W. Graham et al. · The Science of The Total Environment
Open access |
31 Jul 2020 |
435 |
| 34 |
Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis
Ashley Bryce, Alastair D Hay, Isabel Lane et al. · BMJ
ReviewOpen access |
15 Mar 2016 |
425 |
| 35 |
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
Michael H. Cullen, Neil Matthew Steven, Lucinda Jane Billingham et al. · New England Journal of Medicine
Open access |
7 Sep 2005 |
423 |
| 36 |
Mental health in UK Biobank – development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis
Katrina A. S. Davis et al. · BJPsych Open
Open access |
6 Feb 2020 |
412 |
| 37 |
Measuring mortality and the burden of adult disease associated with adverse childhood experiences in England: a national survey
Mark A Bellis, Karen E Hughes, Nicola Leckenby et al. · Journal of Public Health
Open access |
30 Aug 2014 |
407 |
| 38 |
Worldwide rates of diagnosis and effective treatment for cystic fibrosis
Jonathan Guo, Anna Garratt, Andrew M. Hill · Journal of Cystic Fibrosis
Open access |
3 Feb 2022 |
392 |
| 39 |
Community transmission of monkeypox in the United Kingdom, April to May 2022
Roberto Vivancos et al. · Eurosurveillance
Open access |
2 Jun 2022 |
388 |
| 40 |
Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening
Maria A. Loane et al. · European Journal of Human Genetics
Open access |
20 Jun 2012 |
377 |
| 41 |
Development of a framework for the co-production and prototyping of public health interventions
Jemma L. Hawkins, Kim Madden, Adam Fletcher et al. · BMC Public Health
Open access |
4 Sep 2017 |
339 |
| 42 |
Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase
Amit Goyal, Robert Gordon Newcombe, Alok Chhabra et al. · Breast Cancer Research and Treatment
|
15 Mar 2006 |
334 |
| 43 |
A comparison of gender-linked population cancer risks between alcohol and tobacco: how many cigarettes are there in a bottle of wine?
Theresa Hydes, Robyn Burton, Hazel M. Inskip et al. · BMC Public Health
Open access |
27 Mar 2019 |
330 |
| 44 |
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
Josep Vidal‐Alaball, Christopher Butler, Rebecca L. Cannings-John et al. · Cochrane Database of Systematic Reviews
Open access |
4 Jul 2005 |
328 |
| 45 |
Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study
M McGivern et al. · Archives of Disease in Childhood Fetal & Neonatal
|
19 Nov 2014 |
317 |
| 46 |
Four Country Healthcare Associated Infection Prevalence Survey 2006: overview of the results
Edward T. M. Smyth, Gerry McIlvenny, J.E. Enstone et al. · Journal of Hospital Infection
|
12 Jun 2008 |
311 |
| 47 |
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
Katy Turner, Sharon J. Hutchinson, Peter T. Vickerman et al. · Addiction
|
25 May 2011 |
304 |
| 48 |
Health and financial costs of adverse childhood experiences in 28 European countries: a systematic review and meta-analysis
Karen E Hughes, Kat Ford, Mark A Bellis et al. · The Lancet Public Health
ReviewOpen access |
28 Oct 2021 |
302 |
| 49 |
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
Christopher Butler, David Ch. Gillespie, Patrick T. White et al. · New England Journal of Medicine
Open access |
10 Jul 2019 |
287 |
| 50 |
Systematic review and meta‐analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer
Ceri Beaton, Christopher P. Twine, Gethin Llewellyn Williams et al. · Colorectal Disease
ReviewOpen access |
20 Jan 2013 |
281 |